These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 33155505)

  • 1. Autologous fibrin sealant co-delivered with antibiotics is a robust method for topical antibiotic treatment after sinus surgery.
    Aanaes K; Nielsen KG; Arndal E; von Buchwald C; Pressler T; Høiby N
    Acta Otolaryngol; 2021 Feb; 141(2):181-186. PubMed ID: 33155505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
    Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
    J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis.
    Aanaes K; von Buchwald C; Hjuler T; Skov M; Alanin M; Johansen HK
    Am J Rhinol Allergy; 2013 Jan; 27(1):e1-4. PubMed ID: 23406585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis.
    Hodson ME; Gallagher CG; Govan JR
    Eur Respir J; 2002 Sep; 20(3):658-64. PubMed ID: 12358344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD004197. PubMed ID: 19821321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the in vivo efficacy of topical tobramycin against Pseudomonas sinonasal biofilms.
    Chiu AG; Antunes MB; Palmer JN; Cohen NA
    J Antimicrob Chemother; 2007 Jun; 59(6):1130-4. PubMed ID: 17405780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis.
    Berlana D; Llop JM; Manresa F; Jódar R
    Pharmacotherapy; 2011 Feb; 31(2):146-57. PubMed ID: 21275493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriology and treatment of infections in the upper and lower airways in patients with primary ciliary dyskinesia: adressing the paranasal sinuses.
    Alanin MC
    Dan Med J; 2017 May; 64(5):. PubMed ID: 28552099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials.
    Máiz L; Girón RM; Olveira C; Quintana E; Lamas A; Pastor D; Cantón R; Mensa J
    Expert Opin Pharmacother; 2013 Jun; 14(9):1135-49. PubMed ID: 23586963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis upper airways primary colonization with Pseudomonas aeruginosa: eradicated by sinonasal antibiotic inhalation.
    Mainz JG; Michl R; Pfister W; Beck JF
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1089-90. PubMed ID: 22045752
    [No Abstract]   [Full Text] [Related]  

  • 11. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols.
    Taccetti G; Bianchini E; Cariani L; Buzzetti R; Costantini D; Trevisan F; Zavataro L; Campana S;
    Thorax; 2012 Oct; 67(10):853-9. PubMed ID: 22379071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients - can chronic lung infections be postponed?
    Aanaes K; Johansen HK; Skov M; Buchvald FF; Hjuler T; Pressler T; Hoiby N; Nielsen KG; von Buchwald C
    Rhinology; 2013 Sep; 51(3):222-30. PubMed ID: 23943728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into cystic fibrosis microbiology from the European tobramycin trial in cystic fibrosis.
    Govan JR
    J Cyst Fibros; 2002 Dec; 1(Suppl 2):203-8. PubMed ID: 15463836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and future of the aerosoltherapy in the treatment of cystic fibrosis patients infected by Pseudomonas aeruginosa].
    Rognon A; Curti C; Montana M; Terme T; Rathelot P; Vanelle P
    Therapie; 2011; 66(6):481-91. PubMed ID: 22186073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis.
    Adeboyeku D; Scott S; Hodson ME
    J Cyst Fibros; 2006 Dec; 5(4):261-3. PubMed ID: 16807142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of failed eradication of cystic fibrosis-related sinus colonisation by Pseudomonas aeruginosa.
    Linnane B; Kearse L; O'Connell NH; Fenton J; Kiernan MG; Dunne CP
    BMC Pulm Med; 2015 Oct; 15():114. PubMed ID: 26445233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
    Aanæs K
    J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sinus surgery can improve quality of life, lung infections, and lung function in patients with primary ciliary dyskinesia.
    Alanin MC; Aanaes K; Høiby N; Pressler T; Skov M; Nielsen KG; Johansen HK; von Buchwald C
    Int Forum Allergy Rhinol; 2017 Mar; 7(3):240-247. PubMed ID: 27879058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Ryan G; Jahnke N; Remmington T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008319. PubMed ID: 23235659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial.
    Hewer SCL; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Williamson PR;
    Lancet Respir Med; 2020 Oct; 8(10):975-986. PubMed ID: 33007285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.